A multivariate analysis identified serum LDH levels as a significant prognostic predictor and a statistical trend for overall survival of patients with advanced pancreatic cancer after gemcitabine-based chemotherapy [ 30 ].
← all excerpts
Targeting Pyruvate Kinase M2 and Lactate Dehydrogenase A Is an Effective Combination Strategy for the Treatment of Pancreatic Cancer.
1
—
—